A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis
NCT01554982
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
168
Enrollment
INDUSTRY
Sponsor class
Conditions
End Stage Renal Disease
Kidney Failure
Renal Failure
Hyperphosphatemia
ESRD
Interventions
DRUG:
ferric citrate
Sponsor
Keryx Biopharmaceuticals